0001433714-20-000051.txt : 20200603 0001433714-20-000051.hdr.sgml : 20200603 20200603165239 ACCESSION NUMBER: 0001433714-20-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20200603 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20200603 DATE AS OF CHANGE: 20200603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLIGHT HEALTH, INC. CENTRAL INDEX KEY: 0001433714 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 261989091 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36330 FILM NUMBER: 20940648 BUSINESS ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-671-4683 MAIL ADDRESS: STREET 1: 150 SPEAR STREET STREET 2: SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: VENTANA HEALTH SERVICES, INC. DATE OF NAME CHANGE: 20090831 FORMER COMPANY: FORMER CONFORMED NAME: MARIA HEALTH INC DATE OF NAME CHANGE: 20080429 8-K 1 cslt-20200603.htm 8-K cslt-20200603
false000143371400014337142020-06-032020-06-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
June 3, 2020
Date of Report (Date of earliest event reported)
CASTLIGHT HEALTH, INC.
(Exact name of registrant as specified in its charter)
Delaware

001-36330
26-1989091

(State or other jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer
Identification Number)
150 Spear Street, Suite 400
San Francisco, CA 94105
(Address of principal executive offices)

(415) 829-1400
(Registrant’s telephone number, including area code)

Not applicable
(Former name, former address and former fiscal year, if changed since last report)


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class B Common Stock, par value $0.0001 per shareCSLTNew York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.07 Submission of Matters to a Vote of Security Holders.

Castlight Health, Inc. (the “Company”) held its 2020 Annual Meeting of Stockholders on June 3, 2020 as a virtual meeting held over the Internet via live webcast (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on five proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 24, 2020 (the “Proxy Statement”). Present at the Annual Meeting in person or by proxy were holders representing 112,447,749 shares of the Company's Class A and Class B common stock (the "Common Stock"), representing approximately 75.20% of the eligible votes, constituting a quorum.

The matters described below were voted on at the Annual Meeting and the number of votes cast with respect to each matter was as indicated.

(a) Holders of the Company’s Common Stock voted to elect three Class III directors, each to serve until his or her successor has been elected and qualified or until his or her earlier resignation or removal. The final voting results are as follows:

Director NameForWithheldBroker Non-VotesPercentage of Votes in Favor
Michael Eberhard74,460,01618,717,07419,270,65979.91 %
David Ebersman74,357,27818,819,81219,270,65979.80 %
Maeve O’Meara82,154,58811,022,50219,270,65988.17 %

(b) Holders of the Company’s Common Stock voted to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020. The final voting results are as follows:

For88,408,489  
Against23,963,550  
Abstain75,710  

(c) Holders of the Company’s Common Stock did not approve, on a non-binding advisory basis, the compensation paid by the Company to its named executive officers as disclosed in the Proxy Statement. The final voting results are as follows:

For40,297,176  
Against50,548,227  
Abstain2,331,687  
Broker Non-Votes19,270,659  


(d) Holders of the Company’s Common Stock approved, on a non-binding advisory basis, to hold future non-binding advisory votes on the compensation paid by the Company to its named executive officers, on an annual basis. The final voting results are as follows:

1 Year83,149,259  
2 Years380,579  
3 Years9,479,331  
Abstain167,921  
Broker Non-Votes19,270,659  

Based on these results and consistent with the Company’s stockholders’ recommendation, the Company’s Board of Directors has determined that the Company will conduct future stockholder non-binding advisory votes regarding the compensation to be paid by the Company to its named executive officers on an annual basis. This policy will remain in effect until the next stockholder vote on the frequency of stockholder advisory votes on the compensation of named executive officers.



(e) Holders of the Company’s Common Stock voted to approve an amendment to the Company’s certificate of incorporation to effect a reverse stock split as described in the Proxy Statement. The final voting results are as follows:

For111,596,573  
Against705,079  
Abstain146,097  



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CASTLIGHT HEALTH, INC.
Date:June 3, 2020By:/s/ Will Bondurant
Will Bondurant
Chief Financial Officer




EX-101.SCH 2 cslt-20200603.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 3 cslt-20200603_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 4 cslt-20200603_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 cslt-20200603_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 6 cslt-20200603_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT JSON 7 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cslt-20200603.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "cslt-20200603_cal.xml" ] }, "definitionLink": { "local": [ "cslt-20200603_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "cslt-20200603.htm" ] }, "labelLink": { "local": [ "cslt-20200603_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "cslt-20200603_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "cslt-20200603.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cslt", "nsuri": "http://www.castlighthealth.com/20200603", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cslt-20200603.htm", "contextRef": "i1bcc57a71cba44ce8925ff3d950b4d60_D20200603-20200603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.castlighthealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cslt-20200603.htm", "contextRef": "i1bcc57a71cba44ce8925ff3d950b4d60_D20200603-20200603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.castlighthealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 cslt-20200603_htm.xml IDEA: XBRL DOCUMENT 0001433714 2020-06-03 2020-06-03 false 0001433714 8-K 2020-06-03 CASTLIGHT HEALTH, INC. DE 001-36330 26-1989091 150 Spear Street Suite 400 San Francisco CA 94105 415 829-1400 Class B Common Stock, par value $0.0001 per share CSLT NYSE false false false false false false XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.castlighthealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cslt-20200603.htm cslt-20200603.xsd cslt-20200603_cal.xml cslt-20200603_def.xml cslt-20200603_lab.xml cslt-20200603_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 13 0001433714-20-000051-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001433714-20-000051-xbrl.zip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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Cover
Jun. 03, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 03, 2020
Entity Registrant Name CASTLIGHT HEALTH, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36330
Entity Tax Identification Number 26-1989091
Entity Address, Address Line One 150 Spear Street
Entity Address, Address Line Two Suite 400
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94105
City Area Code 415
Local Phone Number 829-1400
Title of 12(b) Security Class B Common Stock, par value $0.0001 per share
Trading Symbol CSLT
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001433714